(VIANEWS) – Shares of TherapeuticsMD (NASDAQ: TXMD) slid 9.63% to $2.44 at 12:29 EST on Wednesday, after three consecutive sessions in a row of losses. NASDAQ is dropping 3.61% to $11,551.99, following the last session’s upward trend. This seems, so far, a very negative trend trading session today.

TherapeuticsMD’s last close was $2.70, 1.82% below its 52-week high of $2.75.


Today’s last reported volume for TherapeuticsMD is 298793 which is 9.39% above its average volume of 273138.

TherapeuticsMD’s Sales

TherapeuticsMD’s sales growth is 33.7% for the present quarter and 29.3% for the next. The company’s growth estimates for the present quarter and the next is 16.7% and 40%, respectively.

TherapeuticsMD’s Revenue

Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.


TherapeuticsMD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.60%, a negative 5.75%, and a positive 7.17%, respectively.

TherapeuticsMD’s highest amplitude of average volatility was 7.14% (last week), 7.09% (last month), and 7.17% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

TherapeuticsMD’s stock is considered to be oversold (<=20).

TherapeuticsMD’s Stock Yearly Top and Bottom Value

TherapeuticsMD’s stock is valued at $2.44 at 12:29 EST, way below its 52-week high of $2.75 and way above its 52-week low of $0.37.

TherapeuticsMD’s Moving Average

TherapeuticsMD’s value is way above its 50-day moving average of $0.66 and way higher than its 200-day moving average of $1.00.

More news about TherapeuticsMD (TXMD).


Please enter your comment!
Please enter your name here